"Psilocybin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major of two hallucinogenic components of Teonanacatl, the sacred mushroom of Mexico, the other component being psilocin. (From Merck Index, 11th ed)
| Descriptor ID |
D011562
|
| MeSH Number(s) |
D03.132.436.613 D03.633.100.473.402.613 D03.633.100.473.914.700
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Psilocybin".
Below are MeSH descriptors whose meaning is more specific than "Psilocybin".
This graph shows the total number of publications written about "Psilocybin" by people in this website by year, and whether "Psilocybin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Psilocybin" by people in Profiles.
-
Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Sci Rep. 2024 11 14; 14(1):28022.
-
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis. Psychiatry Res. 2024 May; 335:115886.
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin. Am J Ther. 2024 Mar-Apr 01; 31(2):e121-e132.
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview. Am J Ther. 2024 Mar-Apr 01; 31(2):e97-e103.
-
Psilocybin-assisted psychotherapy for cancer-related anxiety and depression. Int J Gynecol Cancer. 2023 08 07; 33(8):1327-1328.
-
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. Neuropharmacology. 2022 11 15; 219:109214.
-
Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. CNS Spectr. 2023 Aug; 28(4):416-426.